ClinicalTrials.gg
CompletedNCT03352362Updated May 6, 2019

Comparison of the Effect of Propacetamol, Ibuprofen or Their Combination on Postoperative Pain and Quality of Recovery After Laparoscopic Hernia Repair in Children

An interventional study of ibuprofen (caldolor 10 mg / kg) and propacetamol (denogan 30 mg / kg) in Inguinal Hernia, sponsored by Yonsei University. Completed at 1 site in Korea, Republic of. Open to participants aged 6 Months to 6 Years. Per ClinicalTrials.gov, last updated 2019-05-06.

Sponsored by Yonsei University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
159
Allocation
Randomized
Ages
6 Months to 6 Years
Sex
All
01

Study summary

There are difficulties in the progress of the study and cancel the plan. The purpose of this study is to evaluate the postoperative pain control using non - opioidal analgesics in children. The investigators will investigate the effect of single use and combination of caldorol(ibuprofen) compare to denogan(propacetamol) in children.

Participants who receive the laparoscopic inguinal hernia repair between 6 months and 6 years old are divided 3 groups(caldolor, denogan, combination). Each groups are received a medication by protocol during surgery. After operation patient's pain score and use of additional analgesics are recorded in postanesthesia care unit and general ward.

02

Conditions studied

  • Inguinal Hernia

Browse trials for

03

In context

Hernia, Inguinal

545 studies on the registry are indexed under Hernia, Inguinal; 91 are open to participants now.

This study's enrollment of 159 is above the median of 90 across 397 interventional studies indexed under Hernia, Inguinal.

Browse Hernia, Inguinal studies →

Lead sponsor

Yonsei University is the lead sponsor of 1,420 studies on the registry; 241 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • scheduled to undergo laparoscopic inguinal hernia surgery
  • physical status classification 1 or 2
  • Children aged 6 months to 6 years

Exclusion criteria

Exclusion Criteria:

  • history of Gastrointestinal bleeding
  • history or laboratory finding of suspected renal or hepatic dysfunction
  • bronchial asthma
  • bleeding disorder
  • to NSAID or propacetamol
  • disagreement of investigation
  • The researcher determines that participation is inappropriate due to other reasons.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
159 participants (actual)

Study arms

  • Experimental
    caldolor

    intravenous caldolor injection during intraoperative period

    Drug: ibuprofen (caldolor 10 mg / kg)

  • Active comparator
    denogan

    intravenous denogan injection during intraoperative period

    Drug: propacetamol (denogan 30 mg / kg)

  • Experimental
    combination

    intravenous denogan and caldolor injection during intraoperative period

    Drug: ibuprofen + propacetamol

Interventions

  • Drugibuprofen (caldolor 10 mg / kg)

    Drug page: Ibuprofen InjectionStudies of Ibuprofen InjectionIbuprofen Injection pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Dilution caldolor 10 mg / kg in Hartmann solution to 50 mL - 100 mL and intravenous injection for 30 minutes immediately after induction of anesthesia

  • Drugpropacetamol (denogan 30 mg / kg)

    Drug page: PropacetamolStudies of PropacetamolPropacetamol pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Dilution denogan 30 mg / kg in the dissolved solution to a total of 10 ml and intravenous injection for 10 minutes after the main surgical procedure end

  • Drugibuprofen + propacetamol

    Drug pages: IbuprofenStudies of IbuprofenIbuprofen pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · PropacetamolStudies of PropacetamolPropacetamol pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Dilution caldolor 10 mg / kg in Hartmann solution to 50 mL - 100 mL and intravenous injection for 30 minutes immediately after induction of anesthesia Dilution denogan 30 mg / kg in the dissolved solution to a total of 10 ml and intravenous injection for 10 minutes after the main surgical procedure end

06

What researchers measure

Primary outcomes

  1. additional administration of analgesics

    whether additional analgesics are administered during the postanesthesia care unit due to pain

    Time frame: during stay time in PACU (postanesthesia care unit) average of over 30 minutes up to 1 hour

Secondary outcomes

  1. pain score (FLACC)

    Face-legs-activity-cry-consolability scale(FLACC) - FLACC scale is a measurement used to assess pain for children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain. The scale is scored in a range of 0-10 with 0 representing no pain. The scale has five criteria, which are each assigned a score of 0, 1 or 2.

    Time frame: Participant's pain score is evaluated by FLACC at the time of arriving the postanesthesia care unit(PACU)

  2. pain score (FLACC)

    Face-legs-activity-cry-consolability scale(FLACC) - FLACC scale is a measurement used to assess pain for children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain. The scale is scored in a range of 0-10 with 0 representing no pain. The scale has five criteria, which are each assigned a score of 0, 1 or 2.

    Time frame: Participant's pain score is evaluated by FLACC at 10 minutes after arriving the postanesthesia care unit(PACU)

  3. pain score (FLACC)

    Face-legs-activity-cry-consolability scale(FLACC) - FLACC scale is a measurement used to assess pain for children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain. The scale is scored in a range of 0-10 with 0 representing no pain. The scale has five criteria, which are each assigned a score of 0, 1 or 2.

    Time frame: Participant's pain score is evaluated by FLACC at 20 minutes after arriving the postanesthesia care unit(PACU)

  4. pain score (FLACC)

    Face-legs-activity-cry-consolability scale(FLACC) - FLACC scale is a measurement used to assess pain for children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain. The scale is scored in a range of 0-10 with 0 representing no pain. The scale has five criteria, which are each assigned a score of 0, 1 or 2.

    Time frame: Participant's pain score is evaluated by FLACC at the time of leaving the postanesthesia care unit(PACU) (up to 1 hour)

  5. pain score (CHEOPS)

    Children's Hospital of Eastern Ontario Pain Scale(CHEOPS) - The CHEOPS is an observational scale for measuring postoperative pain in children aged 1-7 years. It can be used to monitor the effectiveness of interventions for reducing the pain and discomfort. It includes six categories of pain behavior, each with 3-4 levels and scores range from 4 points (no pain) to 13 points (the worst pain).

    Time frame: Participant's pain score is evaluated by FLACC at the time of arriving the postanesthesia care unit(PACU)

  6. pain score (CHEOPS)

    Children's Hospital of Eastern Ontario Pain Scale(CHEOPS) - The CHEOPS is an observational scale for measuring postoperative pain in children aged 1-7 years. It can be used to monitor the effectiveness of interventions for reducing the pain and discomfort. It includes six categories of pain behavior, each with 3-4 levels and scores range from 4 points (no pain) to 13 points (the worst pain).

    Time frame: Participant's pain score is evaluated by FLACC at 10 minutes after arriving the postanesthesia care unit(PACU)

  7. pain score (CHEOPS)

    Children's Hospital of Eastern Ontario Pain Scale(CHEOPS) - The CHEOPS is an observational scale for measuring postoperative pain in children aged 1-7 years. It can be used to monitor the effectiveness of interventions for reducing the pain and discomfort. It includes six categories of pain behavior, each with 3-4 levels and scores range from 4 points (no pain) to 13 points (the worst pain).

    Time frame: Participant's pain score is evaluated by FLACC at 20 minutes after arriving the postanesthesia care unit(PACU)

  8. pain score (CHEOPS)

    Children's Hospital of Eastern Ontario Pain Scale(CHEOPS) - The CHEOPS is an observational scale for measuring postoperative pain in children aged 1-7 years. It can be used to monitor the effectiveness of interventions for reducing the pain and discomfort. It includes six categories of pain behavior, each with 3-4 levels and scores range from 4 points (no pain) to 13 points (the worst pain).

    Time frame: Participant's pain score is evaluated by FLACC at the time of leaving the postanesthesia care unit(PACU) (up to 1 hour)

  9. pain score (PPPM scale)

    Parents' Postoperative Pain Measure(PPPM scale): The number of items parents have circled "Yes" are summed for a total score out of 15. A score of at least 6 out of 15 signifies clinically significant pain.

    Time frame: The PPPM scale is measured at 4 hours after surgery

  10. pain score (PPPM scale)

    Parents' Postoperative Pain Measure(PPPM scale): The number of items parents have circled "Yes" are summed for a total score out of 15. A score of at least 6 out of 15 signifies clinically significant pain.

    Time frame: The PPPM scale is measured at 12 hours after surgery

  11. pain score (PPPM scale)

    Parents' Postoperative Pain Measure(PPPM scale): The number of items parents have circled "Yes" are summed for a total score out of 15. A score of at least 6 out of 15 signifies clinically significant pain.

    Time frame: The PPPM scale is measured at 24 hours after surgery

  12. incidence of complications

    incidence of complications in PACU (postanesthesia care unit)

    Time frame: during stay time in PACU (postanesthesia care unit) average of over 30 minutes up to 1 hour

07

Study locations

1 site
  • Department of Anesthesiology and Pain MedicineYonsei University College of Medicine Severance Hospital
    Seoul, 03722, Korea, Republic of
08

References and documents

Publications

  • Lee HM, Park JH, Park SJ, Choi H, Lee JR. Comparison of Monotherapy Versus Combination of Intravenous Ibuprofen and Propacetamol (Acetaminophen) for Reduction of Postoperative Opioid Administration in Children Undergoing Laparoscopic Hernia Repair: A Double-Blind Randomized Controlled Trial. Anesth Analg. 2021 Jul 1;133(1):168-175. doi: 10.1213/ANE.0000000000005284. PubMed 33181557 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2017 to primary completion in Mar 2019, 14 months.

Of 179 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's 14 months is below that.

Counting every sponsor, half of 188 studies reached it within 19 months; a quarter within 9 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 20, 2017
First posted
Nov 24, 2017
StartActual
Dec 15, 2017
Primary completionActual
Mar 8, 2019
CompletionActual
Mar 9, 2019
Last update
May 6, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 6, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03352362
Lead sponsor
Yonsei University
Responsible party
Sponsor
First posted
Nov 24, 2017
Start date
Dec 15, 2017
Primary completion
Mar 8, 2019
Completion
Mar 9, 2019
Last update
May 6, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Ibuprofen Injection · Ibuprofen · Propacetamol

Start the discussion